(Q37271280)

19 August 2017

Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study (English)

1 reference

19 August 2017

1 reference

cervix uterine cancer

1 reference

Thomas Keller

11

0 references

John-Paul Bogers

object named as

Johannes Bogers

Magnus von Knebel Doeberitz

7

0 references

Pere Fusté

0 references

12

object named as

Magnus von Knebel Doeberitz

1 reference

19 August 2017

Hans Ikenberg

1

1 reference

19 August 2017

Christine Bergeron

2

1 reference

19 August 2017

Dietmar Schmidt

3

1 reference

19 August 2017

Henrik Griesser

4

1 reference

19 August 2017

Francisco Alameda

5

1 reference

19 August 2017

Claudio Angeloni

6

1 reference

19 August 2017

Roger Dachez

8

1 reference

19 August 2017

Karin Denton

9

1 reference

19 August 2017

Jalil Hariri

10

1 reference

19 August 2017

Heinrich H Neumann

13

1 reference

19 August 2017

Luis M Puig-Tintore

14

1 reference

19 August 2017

Mario Sideri

15

1 reference

19 August 2017

Susanne Rehm

16

1 reference

19 August 2017

Ruediger Ridder

17

1 reference

19 August 2017

PALMS Study Group

18

1 reference

19 August 2017

language of work or name

English

0 references

publication date

4 October 2013

1 reference

Journal of the National Cancer Institute

19 August 2017

1 reference

19 August 2017

105

1 reference

19 August 2017

20

1 reference

19 August 2017

1550-1557

1 reference

Triage of HPV-positive women in cervical cancer screening

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Human papillomavirus testing in the prevention of cervical cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Biomarkers in cervical cancer screening

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Ink4a/Arf links senescence and aging

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

The 2001 Bethesda System: terminology for reporting results of cervical cytology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Assessment of diagnostic tests when disease verification is subject to selection bias

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Immunocytochemical colocalization of P16(INK4a) and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

Verification bias-corrected estimators of the relative true and false positive rates of two binary screening tests

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3814411

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJT235

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

21 January 2018

1 reference

12 December 2020

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

1 reference

12 December 2020

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

1 reference

12 December 2020

CINtec PLUS immunocytochemistry as a tool for the cytologic diagnosis of glandular lesions of the cervix uteri

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJT235

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

24096620

1 reference